DENTSPLY SIRONA Inc
NASDAQ:XRAY
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
17.26
37.39
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc
Research & Development
DENTSPLY SIRONA Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Research & Development
-$166m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Haemonetics Corp
NYSE:HAE
|
Research & Development
-$59.7m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-2%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Research & Development
-$88.7m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-18%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Research & Development
-$351.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-21%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Research & Development
-$149.6m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-27%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Research & Development
-$83.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-9%
|
|
DENTSPLY SIRONA Inc
Glance View
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in York, Pennsylvania and currently employs 15,000 full-time employees. The firm develops, manufactures and markets solutions, including dental equipment and dental consumable products. The Company’s segments include Technologies & Equipment (T&E) and Consumables. The T&E segment is engaged in designing, manufacturing, sales and distribution of its Dental Technology and Equipment Products and Healthcare Consumable Products. Its products include dental implants, computer-aided design/computer-aided manufacturing systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as consumable medical device products. The Consumables segment is engaged in designing, manufacturing, sales and distribution of the Company's Dental Consumable Products, which include preventive, restorative, endodontic and dental laboratory products. The company also offers treatment planning and a clear aligner solution delivered directly to a consumer's home.
See Also
What is DENTSPLY SIRONA Inc's Research & Development?
Research & Development
-166m
USD
Based on the financial report for Sep 30, 2024, DENTSPLY SIRONA Inc's Research & Development amounts to -166m USD.
What is DENTSPLY SIRONA Inc's Research & Development growth rate?
Research & Development CAGR 3Y
12%
Over the last year, the Research & Development growth was 10%. The average annual Research & Development growth rates for DENTSPLY SIRONA Inc have been 12% over the past three years .
You don't have any saved screeners yet
